Results 211 to 220 of about 133,969 (353)

THE TRIAL OF A JAW PHANTOM PRODUCED AT OUR INSTITUTES

, 1968
Huminori NAKAO, Risuke AKIYOSHI, Masanori SHINNO, Shinichiro Mori, Ken OBA, Yasuo Ogawa, Atushi HATAKEYAMA, Tadashi Ota, Shigemasa Kashiwagi, Takashi Inuzuka, Masasumi HANANO, Nodoka TOBA   +11 more
openalex   +2 more sources

Development of a cornea-equivalent phantom in the terahertz frequency region for 3D temperature rise assessment. [PDF]

Sci Rep
Yamazaki S, Mizuno M, Nagaoka T.
europepmc   +1 more source

Systematic profiling of cancer‐fibroblast interactions reveals drug combinations in ovarian cancer

Molecular Oncology, EarlyView.
Fibroblasts, cells in the tumor environment, support ovarian cancer cell growth and alter morphology and drug response. We used fibroblast and cancer cell co‐culture models to test 528 drugs and discovered new drugs for combination treatment. We showed that adding Vorinostat or Birinapant to standard chemotherapy may improve drug response, suggesting ...
Greta Gudoityte, Osheen Sharma, Laura Leuenberger, Emelie Wallin, Josefin Fernebro, Päivi Östling, Rebecka Bergström, Johan Lindberg, Ulrika Joneborg, Olli Kallioniemi, Brinton Seashore‐Ludlow   +10 more
wiley   +1 more source

The phantom bouquet : a popular treatise on the art of skeletonizing leaves and seed-vessels and adapting them to embellish the home of taste /

Edward Parrish, August Wilhelm
openalex   +2 more sources

Performative Reviews and Phantom Audiences

, 1969
Lynn Deboeck
openalex   +2 more sources

Comprehensive omics‐based classification system in adult patients with B‐cell acute lymphoblastic leukemia

Molecular Oncology, EarlyView.
The COMBAT classification system, developed through multi‐omics integration, stratifies adult patients with B‐cell acute lymphoblastic leukemia(B‐ALL) into three molecular subtypes with distinct surface antigen patterns, immune landscape, methylation patterns, biological pathways and prognosis.
Yang Song, Ting Liu, Qishan Hao, Qiuyun Fang, Xiaoyuan Gong, Yan Li, Zheng Tian, Hui Wei, Min Wang, Jianxiang Wang, Tao Cheng, Yingchang Mi   +11 more
wiley   +1 more source

Comparison of actual and automated CT measurements of urinary stone size: a phantom study. [PDF]

Urolithiasis
Yoon MS, Jang DH, Lee J, Jeong J, Kim DG, Lim H, Lee DK, Oh J.   +7 more
europepmc   +1 more source

Circulating tumor DNA monitoring and blood tumor mutational burden in patients with metastatic solid tumors treated with atezolizumab

Molecular Oncology, EarlyView.
In patients treated with atezolizumab as a part of the MyPathway (NCT02091141) trial, pre‐treatment ctDNA tumor fraction at high levels was associated with poor outcomes (radiographic response, progression‐free survival, and overall survival) but better sensitivity for blood tumor mutational burden (bTMB).
Charles Swanton, Russell W. Madison, Candice Francheska B. Tambaoan, Funda Meric‐Bernstam, Christopher J. Sweeney, Razelle Kurzrock, Howard A. Burris III, David R. Spigel, Hanna Tukachinsky, Jason Hughes, Julia Malato, Bongin Yoo, Tania Szado, Cheryl Schwab, Lincoln W. Pasquina, Amaya Gasco, Katja Schulze, Claire F. Friedman   +17 more
wiley   +1 more source

Inter-phantom variability in digital mammography: implications for quality control. [PDF]

Eur Radiol Exp
Gennaro G, Contento G, Ballaminut A, Caumo F.   +3 more
europepmc   +1 more source

Strategies to reduce the cancer burden and improve access to effective and affordable cancer interventions in Europe

Molecular Oncology, EarlyView.
Comprehensive cancer centre (CCCs) and CCCs of Excellence (CCCoE) integration in healthcare. Through outreach to surrounding community hospitals, CCCs enable wider access to top‐clinical cancer treatments and care, thereby facilitating the swift enrolment of patients into data‐rich clinical trials (PI‐initiated trials testing new concepts, drug ...
Anton Berns, Ulrik Ringborg, Julio Celis, Bengt Jönsson, Michael Baumann   +4 more
wiley   +1 more source